Public company research profile

This public-disclosure research profile is not investment advice. It summarizes historical public filings, source links, confidence context, and hypothetical outcomes so readers can verify the evidence themselves.

Open in CopyWindow

Company research history

Basilea Pharmaceutica AG, Allschwil

Source-transparent disclosure history for this company, built from public CopyWindow signals and previous hypothetical outcomes.

1 disclosure
1 insider
0 cluster signals
0.0% avg. 30d outcome

Company facts

Ticker / ISIN
BSLN / CH0011432447
Exchange
SW
Country
CH
Sector
Not available

Disclosure history

Undisclosed SIX management transaction party T1Q5T000F0, A non-executive member of the board of directors

sell disclosed on 29 May 2026 via SIX management transactions

Transaction value
20.800 CHF
Copy Window
Still fresh
Data Confidence
91%
Previous signal outcome
0.0%